Siemens demonstrated hands-off imaging at the RSNA with a work in progress that turns control of an MR scanner over to remote operators. The goal behind Expert-I, which is pending FDA clearance, is to allow expert collaboration on challenging examinations regardless of how far away the expert may be.
Siemens demonstrated hands-off imaging at the RSNA with a work in progress that turns control of an MR scanner over to remote operators. The goal behind Expert-I, which is pending FDA clearance, is to allow expert collaboration on challenging examinations regardless of how far away the expert may be.
With the necessary software and a high-speed connection, experts can work an MR console from their PCs while patients are being scanned, according to the company. Patient set-up, sequences, and imaging data can be viewed in real-time.
Siemens demonstrated the capability in its exhibit booth utilizing a real-time link between the University of California-Los Angeles and Northwestern University in Chicago.
Other Siemens MR introductions include syngo Susceptibility Weighted Imaging (SWI), which promises to better visualize bleeding in stroke and brain trauma patients, contusions and shearing injuries, and minute intracranial vascular malformations. A body diffusion technique, called syngo REVEAL, helps differentiate lesions throughout the body, particularly malignant from benign ones. Syngo GRAPPA offers faster spine and cardiac imaging, with a small field-of-view to provide high spatial resolution.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.